<http://www.reactome.org/biopax/48892Evidence1892> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.biopax.org/release/biopax-level3.owl#Evidence> .
<http://www.reactome.org/biopax/48892Evidence1892> <http://www.biopax.org/release/biopax-level3.owl#comment> "FRS2beta is activated through tyrosine phosphorylation catalyzed by the protein kinase domain of the activated FGFR. By sequence comparison, FRS2beta has the 2 SHP2-binding sites and has three of the four GRB2-binding sites."^^<http://www.w3.org/2001/XMLSchema#string> .
<http://www.reactome.org/biopax/48892Evidence1892> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/9182757> .
<http://www.reactome.org/biopax/48892Evidence1892> <http://www.biopax.org/release/biopax-level3.owl#xref> <http://identifiers.org/pubmed/12419216> .
<http://www.reactome.org/biopax/48892Evidence1892> <http://www.biopax.org/release/biopax-level3.owl#evidenceCode> <http://www.reactome.org/biopax/48892EvidenceCodeVocabulary1> .